EAN Neuro-DEI Hub

This EAN Neuro-DEI Hub serves as a centralised, accessible platform for resources on Diversity, Equity, and Inclusion (DEI) in neurology.
It supports and promotes knowledge sharing relating to the impact of gender, sex, and diversity in neurological diseases. By consolidating relevant materials, it enhances access for neurologists and stakeholders worldwide, provides a hub for EAN DEI initiatives, and fosters collaboration across professional societies with the aim of building a more inclusive neurological community and increase the visibility of DEI efforts accross Europe and beyond.

Filter the category according their assigned format.
| Neurodegenerative  

Researchers analyzed data from two multicenter cohorts, comparing behavioral, cognitive, and neuroimaging features between genetic and sporadic bvFTD…

more...
| Neurodegenerative  

This study explored how social determinants influence Lewy body dementia (LBD) onset and whether these effects differ by sex. Participants with LBD…

more...
| Neurodegenerative  

This review examines sex differences in dementia with Lewy bodies (DLB) across epidemiology, clinical features, pathology, biomarkers, progression,…

more...
| Neurodegenerative  

Recently, scientists have come to recognize that the factors underlying the sex gap in the prevalence of Alzheimer disease are very complex, involving…

more...
| Neurodegenerative  

Background and Objectives: Currently, no tool exists to predict clinical outcomes in patients with advanced Parkinson's disease (PD) under…

more...
| Neurodegenerative  

The impact of sex and gender on disease incidence, progression, and provision of care has gained increasing attention in many areas of medicine.…

more...
| Neurodegenerative  

This meta-analysis investigated whether females show faster tau accumulation than males in the context of high β-amyloid (Aβ) levels, a hallmark of…

more...
| Neurodegenerative  

The impact of sex and gender on disease incidence, progression, and provision of care has gained increasing attention in many areas of medicine.…

more...
| Neurodegenerative  

Sex and Gender Differences in Alzheimer’s Disease: The Women’s Brain Project offers for the first time a critical overview of the evidence documenting…

more...
| Neurodegenerative  

This study explored gender differences in willingness to participate in Alzheimer's disease (AD) clinical trials and related procedures among 2,544…

more...
| Neurodegenerative  

The Clinical Dementia Rating Sum of Boxes (CDR-SB) is a staging scale for Alzheimer’s disease (AD) and is commonly used as an outcome in clinical…

more...
| Neurodegenerative  

Sex differences in the clinical phenotype and progression of AD have been reported, indicating that women are protected relative to men at the…

more...